药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halofantrine
Canrenone
Canrenone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Ertugliflozin
Ertugliflozin may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Isosorbide
Isosorbide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Efonidipine
Efonidipine may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Potassium citrate
Potassium citrate may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Canrenoic acid
Canrenoic acid may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Azosemide
Azosemide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Ularitide
Ularitide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Tienilic acid
Tienilic acid may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Piretanide
Piretanide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Theobromine
Theobromine may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Drospirenone
Drospirenone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Quinethazone
Quinethazone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Mersalyl
Triethylenetetramine may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Canagliflozin
Triethylenetetramine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Halofantrine
Lithium carbonate
Triethylenetetramine may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Halofantrine
Plazomicin
Triethylenetetramine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Halofantrine
Nedaplatin
Triethylenetetramine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
Halofantrine
Isepamicin
Isepamicin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
Halofantrine
Sisomicin
Sisomicin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.